APA

Langer C. J., Gadgeel S. M., Borghaei H., Papadimitrakopoulou V. A., Patnaik A., Powell S. F., Gentzler R. D., Martins R. G., Stevenson J. P., Jalal S. I., Panwalkar A., Yang J. C., Gubens M., Sequist L. V., Awad M. M., Fiore J., Ge Y., Raftopoulos H. & Gandhi L. (20170526). Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. : The Lancet. Oncology.

Chicago

Langer Corey J, Gadgeel Shirish M, Borghaei Hossein, Papadimitrakopoulou Vassiliki A, Patnaik Amita, Powell Steven F, Gentzler Ryan D, Martins Renato G, Stevenson James P, Jalal Shadia I, Panwalkar Amit, Yang James Chih-Hsin, Gubens Matthew, Sequist Lecia V, Awad Mark M, Fiore Joseph, Ge Yang, Raftopoulos Harry and Gandhi Leena. 20170526. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. : The Lancet. Oncology.

Harvard

Langer C. J., Gadgeel S. M., Borghaei H., Papadimitrakopoulou V. A., Patnaik A., Powell S. F., Gentzler R. D., Martins R. G., Stevenson J. P., Jalal S. I., Panwalkar A., Yang J. C., Gubens M., Sequist L. V., Awad M. M., Fiore J., Ge Y., Raftopoulos H. and Gandhi L. (20170526). Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. : The Lancet. Oncology.

MLA

Langer Corey J, Gadgeel Shirish M, Borghaei Hossein, Papadimitrakopoulou Vassiliki A, Patnaik Amita, Powell Steven F, Gentzler Ryan D, Martins Renato G, Stevenson James P, Jalal Shadia I, Panwalkar Amit, Yang James Chih-Hsin, Gubens Matthew, Sequist Lecia V, Awad Mark M, Fiore Joseph, Ge Yang, Raftopoulos Harry and Gandhi Leena. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. : The Lancet. Oncology. 20170526.